Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs – Business Intelligence Info

TheGoogle-fundedstartupCalico,aswithmanyofthetech-originatingfirmsforayingintothelifesciences,hasaloftygoal:totacklethespectrumof“aging-related”diseases,whichencompasseseverythingfromParkinson’stoAlzheimer’stocancer。

Whiletheoutfitisnotoriouslycageyaboutitswork,it’scertainlynotshyaboutstrikinguppartnerships。

ThelatestonecameonThursdayafternoon,whenthebiotechC4Therapeuticsannouncedafive-yearresearchcollaborationwithCalicotodevelopdrugsfor“diseasesofaging,”includingcancer。

There’snotawholelotinthewayofdetails。

Thefirmswill“leverageC4T’sexpertiseandcapabilitiesintargetedproteindegradationtojointlydiscoverandadvancesmallmoleculeproteindegradersastherapeuticagentstoremovecertaindisease-causingproteins,”accordingtoapressrelease。

Insimplerterms,thefirmswantstocreatemedicinestosniffoutproteinsthatmayhelpcausecancersanddestroythem。

“Weknowfromdecadesoftranslationalresearchthatitcanbeincrediblychallengingtofindeffectivepharmacologicinhibitorsofmanyofthebiologicallywell-validatedtargets,particularlyincancer,”saidHalBarron,RDchiefoveratCalico,inastatement。

“Throughthealternativestrategyofspecificallytargetingsuchproteinsfordegradation,webelievewehavetheopportunitytoidentifypromisingnewtherapeuticsincancerandinotherdiseasesaswell。



Beyondthat,weknowverylittle,includingwhatotherdiseasetargetsorspecificcancerswillbeCalico’sandC4T’sfocusastheypursuepreclinicalexperimentalmolecules。

CalicohaspreviouslystruckpartnershipswithacademicinstitutesliketheUniversityofCalifornia,SanFranciscoandbiopharmacompaniessuchasAbbVie。

ThisstoryoriginallyappearedonFortune。

com。

Copyright2017

Letsblockads!

(Why?

)

BigData–VentureBeat